
Abacavir is an NRTIA type of anti-HIV drug that works by inhibiting a stage of the HIV life cycle called reverse transcription. Non-nucleosides work in a similar way, but are chemically different. which is highly potent in people who have not taken antiretrovial therapy and is also often effective in people who have taken HIV treatments before.
A main concern with any regimen containing abacavir is the possibility of developing a severe hypersensitivity rection to the drug. It is also not recommended for people already at risk of heart attackA life-threatening emergency in which the blood supply to the heart is suddenly cut off, causing the heart muscle (myocardium) to die from lack of oxygen..
However, abacavir is one of the antiretroviralsA medication or other substance which is active against retroviruses such as HIV. that can cross the blood-brain barrierA selective barrier (obstacle) between circulating blood and brain tissues that prevents damaging substances from reaching the brain. Certain compounds readily cross the blood-brain barrier; others are completely blocked. and combat HIV in the central nervous system and reduce viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. in the cerebrospinal fluid.
| Generic name: | abacavir |
|---|---|
| Pronunciation: | uh-BACK-aveer |
| Brand name: | Ziagen |
| Also known as: | 1592U89 |
| Drug class: | nucleoside analogue |
| Availability in Australia: |
|
| Presentation: | 300mg tablet;20mg per mL, 240mL oral solution |
| What the treatment guidelines say: | The Guidelines note that abacavir can cause a potentially fatal hypersensitivity reaction. Symptoms of hypersensitivity may include fever, rash, nausea, vomiting, malaise or fatigue, loss of appetite, and/or respiratory symptoms such as sore throat, cough, shortness of breath. Abacavir may also cause a rare but potentially life-threatening toxicity called lactic acidosis with hepatic steatosis. |
| Links: |
|
Like all anti-HIV drugs, abacavir must be taken in combination with other drugs to be completely effective. Commonly, abacavir is combined with one other nucleoside (NRTI) drug> and either a protease inhibitor or non-nucleoside, although other combinations are sometimes used. Your doctor will advise you on the right combination of drugs to suit your circumstances.
The normal adult dose is one 300mg tablet twice a day or two 300mg tablets once a day.
For children and adolescents age 3 months to 16 years, the recommended dosage is 8 mg/kg twice a day (up to a maximum of 300 mg twice a day).
Regardless of what you read on this website or elsewhere, you should always take your medications according to your doctor's instructions. If you're unsure, speak to your doctor or pharmacist.
Abacavir may be taken with or without food.
All drugs can produce side effects in some people. These may be mild, moderate or severe, so you should be aware of potential side effects before starting any drug, and speak to your doctor if you experience side effects that concern you.
It's unlikely you will experience all of these side effects, and you may not experience any side effects at all. Before starting any new drug, ask your doctor about side effects you might experience and discuss strategies for dealing with side effects if they do occur. If you experience any significant side effect you should continue taking your medicine and see your doctor as soon as possible.
| Attachment | Size |
|---|---|
| gwcziagt20908.pdf | 37.93 KB |